Yes, infants will soon be targeted for gene modification serums. Serums are noted here due to the recent CDC reclassification of what a vaccine is. It’s hard to keep up with what a vaccine is anymore.

Before the modification, the definition for vaccination read, “the act of introducing a vaccine into the body to produce immunity to a specific disease.” Now, the word “immunity” has been switched to “protection”.

The term vaccine also got a makeover. The CDC’s definition altered from “a product that stimulates a person’s immune system to produce immunity to a specific disease” to the current “a preparation that is used to stimulate the body’s immune response against diseases.”

It can be reasonably speculated that the unannounced changes were the CDC’s attempt to hide the fact that COVID-19 vaccines are not 100% safe & effective at preventing COVID-19 infection.

In the midst of the confusion, Pfizer has offered a glimpse of its designated timeline for permission of the Wuhan coronavirus (COVID-19) vaccine in kids as young as 6 months old.

We need to ask ourselves if these serums are suitable to be injected into infants as we witness guidelines and data changes every other week as we notice word games and changing definitions and massive changes to standard procedures have all changed, especially in 2019 and 2020.

– The WHO has changed the definition of “pandemic”.

– The CDC essentially changed the meaning of “cause of death” by changing the rules for death certificates in March of 2020, but ONLY FOR COVID-10 — and stated that .this will result in the ’cause of death’ being COVID-19 more often than not.

– S medical ‘case’ used to be someone who was actively sick with symptoms, not anyone who had a positive test result from a test NOT suitable for diagnosing a disease — as is clearly stated on the EUA (emergency use authorization) for PCR tests used for COVID-19. Also, in the package inserts/instructions for the tests.

– Even ‘risk’ has been redefined: even with the CDC’s inflated data, those 18 & under have a virtually and statistically ZERO chance of dying from COVID-19.

– Even with the inflated death counts, the CDC’s data shows that those 30 & under have just a slightly higher chance of dying than zero.

– Overall survival rate for people of all ages is around 99.87% or so — IF one gets the virus and becomes ill.

Frank D’Amelio, Pfizer’s chief financial officer, said the company plans to file for an emergency use authorization for younger kids “in a month shortly thereafter,” so long as all the data is positive. The timeline will depend upon the findings of in-house trials checking whether the vaccines are safe and effective in kids aged 6 months to 5 years.

“We would anticipate having information for children between the ages of 6 months and 5 years of ages that we would submit with the FDA [Food and Drug Administration],” states D’Amelio at the Morgan Stanley Global Healthcare Conference. “I’ll call it in the weeks quickly after the filing of the information for the 6- to 11-year-olds.”

Pfizer is currently pushing to get emergency use authorization from the FDA for the COVID-19 vaccine to be given to kids aged six to 11 by October.

Big Pharma continues to insist that kids are required to get immunized, although they have represented less than 0.25 percent of all COVID-19 deaths in states that report pediatric cases. Seven states have reported no child deaths, while other states have reported that kids made up as low as 0.03 percent of all fatalities.

According to the American Academy of Pediatrics and the Children’s Hospital Association, in the U.S., children represent about 13% of all COVID-19 cases. Research suggests that children younger than ages 10 to 14 are less likely to become infected with the virus that causes COVID-19 compared to people age 20 and older.

The Pfizer vaccine for the youngest age group is less potent than the others. Children aged between six months and five years of age are given a 3 microgram vaccine throughout clinical trials, compared to 10 micrograms for those aged 5 to 11 and 30 micrograms for adults.

The plan to immunize kids as young as six months old is expected to cause international debate.

Surprisingly, some moms and dads are currently looking for COVID-19 vaccine trials for their kids. Rachael DiFransico has registered her 14-month-old daughter Sybil in a study testing whether a COVID-19 vaccine works securely in children.

“ This trial is our best contended getting the vaccine as rapidly as possible,” stated Ms. DiFransico, who said she wanted Sybil to be able to spend more time with other children and extended households. “We desire some form of normalcy for her.” Related: (Oxford Vaccine Group hires kids for coronavirus vaccine trials.).

More than 3,000 families have called Vanderbilt University Medical Center to offer about 150 slots in Moderna’s pediatric trial.

Children are more likely to get myocarditis from vaccines than getting hospitalized with COVID-19.

Those parents and households probably do not know that kids are more likely to get a long-lasting disease from the COVID-19 vaccine than falling seriously ill with the illness.

Initial trials of the Pfizer vaccine for teenage kids and young adults have shown that less than 1 in 10,000 people are under threat of having heart inflammation called myocarditis.

On the other hand, the most recent official data from the Geographic Information Systems (GIS) shows that the COVID-19 hospitalization rate among kids between 5 and 17 years old is just 0.9 per 100,000 (0.09 per 10,000). Information also shows that their hospitalization rate is way below the 14.8 per 100,000 (1.48 per 10,000) among the highly-vaccinated over-65 age.

While the age groups are not precisely similar, it is clear that kids are much more secure without the vaccine. And contrary to what members of the mainstream media state, myocarditis does not disappear quickly.

No case of myocarditis is “moderate”.

A cardiologist who treated a child struggling with myocarditis after getting immunized versus COVID-19 has said that “no case of myocarditis is moderate”.

The incidence of Covid-19-induced myocarditis is not well developed. In late July, stunning findings from a research study published in JAMA Cardiology suggested that after being screened through heart magnetic resonance imaging, 60% of Covid-19 survivors (independent of the severity of the health problem) had established myocarditis.

Additionally, a later research study also released in JAMA showed that 12 out of 26 professional athletes had indications of either present or past myocarditis.

If these findings are to be theorized to the general population, then there are likely many cases among individuals who may not know they are at threat. This is particularly appropriate for young grownups, who are most likely to develop myocarditis and less likely to develop a severe case of the disease.

Myocarditis is challenging to detect, making it challenging to systematically approximate incidence among Covid-19 survivors. Offered increasing case numbers, such research, and screening among patients experiencing myocarditis signs after healing is of terrific significance to avoid and alleviate more complications.

Fourteen-year-old Aiden Jo received his first dose of Pfizer’s COVID-19 vaccine on May 12. On June 10, he woke up in the middle of the night experiencing chest discomfort and trouble breathing.

The kid’s mother, Emily, rushed him to the medical facility where he was ultimately dealt with for myocarditis. Emily stated that she had been under the impression that the unfavorable effects of COVID-19 vaccines are uncommon and mild.

“What they didn’t discuss is that mild means medical facility care and follow-up care indefinitely,” she informed activist group Children’s Health Defense.

“They’re not discussing what moderate myocarditis implies. Aiden’s cardiologist told us no case of myocarditis is moderate. That’s like stating a heart attack is mild”.

Aiden is now forced to sit out gym activities, avoid recess and prevent running around and playing outside with his buddies due to how easily he gets worn out and how inadequately his heart can handle the tension of activity. His mother also faces thousands of dollars in healthcare.

Myocarditis reduces your heart’s ability to pump and can cause rapid or abnormal heartbeats. Extreme cases of myocarditis can lead to cardiac arrest, stroke, cardiac arrest, and an unexpected heart attack. Indications of myocarditis in children include chest discomfort, breathing problems, abnormal heartbeats, fast breathing, fever, and fainting.

Children can get better immunity from catching COVID-19.

Professionals state kids can improve immunity from catching the virus naturally instead of getting one dose of a vaccine.

Teacher David Livermore, a microbiologist at the University of East Anglia, claims that it is “pretty meaningless” to vaccinate children who face such a little danger of falling seriously ill with COVID-19.

According to Livermore, kids are most likely to establish more security from capturing the virus in a similar way regarding how they develop immunity versus other seasonal illnesses.

COVID-19 vaccines work by teaching the body’s immune system to acknowledge the virus and give it the power to combat it off in the future.

But some studies have recommended vaccine-triggered immunity begins to wane within six months, while some research studies have shown that individuals who have recovered from the infection might be safeguarded for a longer period.

Dr. Michael Yeadon replied in a recent public social media comment to a colleague in the UK, “All vaccines against the SARS-COV-2 virus are by definition novel. No candidate vaccine has been… in development for more than a few months.” Yeadon then went on to declare, “If any such vaccine is approved for use under any circumstances that are not EXPLICITLY experimental, I believe that recipients are being misled to a criminal extent. This is because there are precisely zero human volunteers for…whom there could possibly be more than a few months past-dose safety information.”

Yeadon spells out his credentials in the comment, “I have a degree in Biochemistry & Toxicology & a research-based Ph.D. in Pharmacology. I have spent 32 years working in pharmaceutical R&D, mostly in new medicines for disorders of lung & skin. I was a VP at Pfizer & CEO…. of biotech I founded (Ziarco — acquired by Novartis). I’m knowledgeable about new medicine R&D.” He was formerly with Pfizer as a Scientific Researcher and Vice President.

mRNA vaccines — a new era in vaccinology

The fact that an entirely new RNA vaccine technology is being injected into babies which, before recently, has never been used before in humans is a danger signal that should not be ignored. Exogenous mRNA is inherently immunostimulatory, and this feature of mRNA could be beneficial or detrimental. It may provide adjuvant activity and may inhibit antigen expression and negatively affect the immune response.

The paradoxical effects of innate immune sensing on different formats of mRNA vaccines are incompletely understood. Potential safety concerns include local and systemic inflammation, bio-distribution and persistence of expressed immunogens, stimulation of autoreactive antibodies, and potential toxic effects of non-native nucleotides and delivery system components.

An mRNA-based vaccine could also induce potent type I interferon responses, which have been associated not only with inflammation but also potentially with autoimmunity. Another potential safety issue could be derived from the extracellular RNA which has been shown to increase the permeability of tightly packed endothelial cells and may promote blood coagulation and pathological thrombus formation.

An Evidence Review from the Penn Medicine Center for Evidence-based Practice December 2020

“The current evidence base on messenger RNA (mRNA) vaccines is made up entirely of small early-stage trials, nearly all of which examined only short-term outcomes. They lack sufficient power for testing the statistical significance of most results, and for assessing the risk of serious but uncommon adverse events.

The size of these trials and their dual purpose in evaluating dosing and safety precludes quantitative synthesis or GRADE analysis of their results, but there are a few trends that appear to be consistent across the different studies.

Systemic adverse effects such as fatigue, headache, muscle aches, and chills are common following administration of mRNA vaccines, but they usually resolve within a day or two. Localized adverse effects, most notably pain at the injection site, are also common, and also resolve within a day or two.

Larger clinical trials of mRNA vaccines against the SARS-CoV-2 coronavirus are in progress, and their results are expected in mid2021.

Once evidence from those trials is published, more certain conclusions about the safety of these vaccines may be reached. Additional trials will be necessary to determine the relative safety of mRNA vaccines and vaccines using more established technologies.

Clinical guidance specific to the use of mRNA vaccines is lacking at this time, because of the lack of clinical evidence”.

The rate of severe adverse effects (severe enough to interfere with a person’s daily activities) appears to be in the range of 5 to 10 percent. The rate and severity of adverse events increase with the dose of vaccines. The rate and severity of adverse events also appear to be greater following the second dose of vaccine than following the first.

Researchers in a study carried out in Israel have discovered that Delta Variant was 27 times more likely to break through Pfizer protection from January-February and cause symptoms than it was to penetrate natural immunity from the same period

People offered 2 doses of Pfizer’s COVID-19 vaccine are almost 6 times more likely to contract a delta infection and 7 times more likely to have symptomatic illness than those who recovered. “This analysis demonstrated that natural immunity pays for longer-lasting and stronger defenses against infection, symptomatic disease, and hospitalization due to the delta version,” the researchers say.

The analysis also revealed that security from an earlier infection subsides with time. The risk of a vaccine-breakthrough delta case is 13 times greater than the danger of establishing a 2nd infection when the initial illness took place throughout January or February 2021.

Don’t edit the human germ line

Heritable human genetic modifications pose serious risks, and the therapeutic benefits are tenuous, warns Edward Lanphier, Fyodor Urnov, and colleagues.

There are numerous plausible biological mechanisms for the prospective adverse effects of all the vaccines in the pipeline for COVID-19.

The history of vaccination is loaded with clinical proof of negative impacts through enhanced pathogenicity, mutation, recombination, induced immune system dysfunction, and different non-specific effects following vaccination despite regulatory approval, prior medical trials, and other corporate-sponsored studies that were declared to be evidence of safety.

The fundamental danger of injecting microbial protein pieces, pollutants, DNA, and other foreign materials into the body is well documented in the clinical literature. Almost all vaccines consist of such hazardous foreign fragments and products and are unavoidably hazardous.

Moreover, direct exposure of the vaccine to other environmental threats (pesticides, air contaminants, 5G radiation, ionizing radiation, etc.) resulting in synergistic unfavorable impacts not caught by business-sponsored “security” research studies is likewise another possible system that may lead to intense or long-lasting injury, consisting of death.

Safety evaluations under the corporate-dominated scientific scene are grossly insufficient and often erroneous. Pre-clinical studies and scientific trials are done or sponsored by the real corporations who sell the vaccines and they do not effectively address the possible negative effects that can not be discovered by the corporate-sponsored research studies.

There are no independent studies that could validate the claims of the vaccine manufacturers. For that reason, there is no reason to believe that the prospective gain from an approaching COVID-19 vaccine would surpass the prospective negative effects, despite guarantees of security by the vaccine industry, worldwide organizations, federal governments, and mainstream medical science groups.

Bill Gates, the mRNA vaccine maker consisting of Pfizer/BioNTech and Moderna, and their close allies such as Dr. Tony Fauci of NIAID are playing fast and loose with human lives in their rush to get these speculative vaccines into our bodies.

The same Dr. Fauci and his NIAID own the patent on a vaccine for dengue fever known as Dengvaxia, marketed by Sanofi-Pasteur and promoted as a “vital” vaccine by Tedros’ WHO because 2016.

Robert F. Kennedy Jr. noted that Fauci and NIAID “understood from the medical trials that there was a problem with paradoxical immune action,” but they offered it to numerous hundred thousand Filipino kids anyhow. It was estimated that as many as 600 immunized kids died before the federal government stopped the vaccinations.

The Dengvaxia vaccine fiasco in the Philippines also illustrates the danger of rushing a vaccine and allowing corporate interests driven by market forces to address people’s health needs. As a result, many of the vaccinated suffered or died after a botched mass vaccination program.

The reputable Precautionary Principle — if in serious doubt, do not — is being disregarded by Fauci, Pfizer/BioNTech, and others in rushing to approve the injections of mRNA vaccines in infants for coronavirus.

The final conclusion is that there is no reason to rush an experimental gene modification serum into infants now or in the future.

Steafon Perry

Steafon is a Writer, Author, Content Strategist, Copy Editor, Copywriter, Developmental Editor, Editor, Ghostwriter, and Managing Editor.